Posts

Posted on

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

  • Hemopatch Sealing Hemostat with room temperature storage now available in Europe
  • New product evolution enables direct accessibility in the operating room
  • Innovation is a direct result of collaborative efforts with surgeons, helping to ensure that customer needs are met and promoting enhanced patient care

VIENNA–(BUSINESS WIRE)–
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe.

“For over a decade, Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and hemostasis,” said Steve Wallace, president, Advanced Surgery at Baxter. “The product evolution to include room temperature storage is a result of close collaboration between surgeons and Baxter. Removing the need for refrigeration addresses the needs of our customers to have the product on hand in critical situations. We are proud to continue Baxter’s legacy of innovation in sealing and hemostasis.”

HemopatchSealing Hemostat is a ready-to-use absorbable collagen pad intended for tissue sealing, dura sealing and hemostasis, and is effective and safe to use in open surgery and minimally invasive surgery. In a registry of real-world data across Europe, the product has been shown to achieve rapid and sustainable hemostasis in many surgical specialties.1

General Surgeon, Prof. Dr. med. Selman Uranüs said, “More than 10 years ago, I first used Hemopatch Sealing Hemostat for experimental testing. Since then, I have been using it in my daily practice because of its unique characteristics as a sealing hemostatic patch, especially in laparoscopic surgery. In my opinion, eliminating the need for refrigeration and increasing product shelf life are crucial improvements because it enables surgeons to have the product available in the operating room when it matters most. After application, the product shows an enhanced adhesive strength supporting us surgeons to achieve better surgical outcomes.”2

For more information on Hemopatch Sealing Hemostat with room temperature storage, visit https://advancedsurgery.baxter.eu/hemopatch

About Hemopatch Sealing Hemostat

Hemopatch Sealing Hemostat consists of a soft, thin, pliable, flexible pad of collagen derived from bovine dermis, coated with NHS-PEG (pentaerythritol polyethylene glycol ether tetra-succinimidyl glutarate). Due to its flexible structure, the application of Hemopatch Sealing Hemostat to the site where hemostasis / sealing is desired is easily controlled. For differentiation, the non-coated side is marked with blue squares using a biocompatible colorant.3

About Baxter

Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

INDICATIONS

Hemopatch Sealing Hemostat is indicated as a hemostatic device and surgical sealant across various soft tissues (cardiovascular, connective tissue, parenchyma, serosa, viscera), and dura for procedures in which control of mild or moderate bleeding or leakage of other body fluids or air by conventional surgical techniques is either ineffective or impractical. Hemopatch Sealing Hemostat may be used to augment dura closure techniques to close small dural defects (≤3mm) following traumatic injury, excision, retraction or shrinkage of the dura mater.

IMPORTANT RISK INFORMATION

  • Hemopatch Sealing Hemostat is not recommended to be used in pulsatile, severe bleedings.
  • The use of Hemopatch Sealing Hemostat is not recommended in the presence of an active infection.
  • When used in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord, the brain and/or cranial nerves, care should be exercised to avoid overpacking as Hemopatch Sealing Hemostat may expand upon absorption of liquid, creating the potential for neural damage.
  • Hemopatch Sealing Hemostat is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis and sealing.
  • Do not compress Hemopatch Sealing Hemostat into blood vessels or use intravascularly.

Rx Only. For safe and proper use please refer to full device Instructions for Use for Contraindications, Warnings, and Precautions.

Forward-Looking Statements

This release includes forward-looking statements concerning potential benefits associated with Hemopatch Sealing Hemostat. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter’s most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.

Hemopatch Sealing Hemostat and Baxter are registered trademarks of Baxter International Inc.

____________________

1 Lombardo C, Lopez-Ben S, Boggi U, Gutowski P, Hrbac T, Krska L, Marquez-Rivas J, Russello D, York E, Zacharias M. Hemopatch® is effective and safe to use: real-world data from a prospective European registry study. Updates Surg. 2022 Oct;74(5):1521-1531. doi: 10.1007/s13304-022-01353-y. Epub 2022 Aug 20. PMID: 35986865; PMCID: PMC9481486.

2 Prof. Dr. med. Selman Uranüs, is one of the speakers at the symposium and has signed a speaker agreement

3 IFU Hemopatch Sealing Hemostat 09/2024

 

Media Contact

Peggy Dekker-Kühnen, (224) 948-5353

[email protected]

Investor Contact

Clare Trachtman, (224) 948-3020

KEYWORDS: Austria Europe

INDUSTRY KEYWORDS: Research Medical Devices Medical Supplies Other Health Managed Care Health General Health Other Science Science

MEDIA:

Logo
Logo
Posted on

Nuvve Partners with Jefferies to Power Infrastructure Financing for “Electrify New Mexico”

Nuvve Partners with Jefferies to Power Infrastructure Financing for “Electrify New Mexico”

SAN DIEGO–(BUSINESS WIRE)–Nuvve Holding Corp. (Nasdaq: NVVE), a global leader in grid modernization and vehicle-to-grid (V2G) technology, today announced it has selected Jefferies LLC, one of the world’s leading full-service investment banking and capital markets firms, as its exclusive infrastructure financing partner for the Electrify New Mexico initiative.

Jefferies will work with Nuvve to structure and secure capital markets transactions to fund the buildout of electric vehicle (EV) charging infrastructure, grid-integrated mobility hubs, and other clean energy assets tied to Nuvve’s landmark contract awarded by the State of New Mexico.

“Jefferies brings Electrify New Mexico closer to reality and offers a strong endorsement of both our vision and our leadership in grid modernization,” said Gregory Poilasne, CEO and Founder of Nuvve. “We’re not just planning for the future; we’re building it with key strategic partners committed to building this critical infrastructure.”

Jefferies brings deep expertise in energy infrastructure finance and has a global reputation for transformative clean energy projects in the U.S. Their global track record in financing clean energy projects positions them as an ideal partner to unlock scalable capital solutions for one of the most ambitious state electrification efforts in the U.S. Their involvement exhibits growing investor confidence in Nuvve’s business model and the long-term potential of the Electrify New Mexico initiative.

The announcement comes as New Mexico continues to demonstrate strong political movement to lead on electrification and grid innovation. During the most recent legislative session, nearly 100 bills were introduced that directly or indirectly support clean energy goals, including proposed investments in EV infrastructure, grid resilience, and zero-emission transportation. This reflects a clear commitment to building a more sustainable energy future.

“We’re executing on a bold and necessary transformation,” said Ted Smith, CEO of Nuvve New Mexico LLC. “With partners like Jefferies and strong momentum at the state level, we’re building a coalition capable of making New Mexico a national leader in grid innovation and clean energy deployment.”

To support the project’s success, Nuvve formed Nuvve New Mexico LLC, a regional subsidiary dedicated to executing the statewide contract and spearheading local implementation.

About Nuvve

Founded in 2010, Nuvve Holding Corp. (Nasdaq: NVVE) has successfully deployed vehicle-to-grid (V2G) on five continents, offering turnkey electrification solutions for fleets of all types. Nuvve combines the world’s most advanced V2G technology and an ecosystem of electrification partners, delivering new value to electric vehicle (EV) owners, accelerating the adoption of EVs, and supporting a global transition to clean energy. Nuvve is making the grid more resilient, transforming EVs into mobile energy storage assets, enhancing sustainable transportation, and supporting energy equity in an electrified world. Nuvve is headquartered in San Diego, Calif., and can be found online at nuvve.com.

Media Contact For Nuvve:

Wes Robinson

[email protected]

(626) 201-2928

KEYWORDS: United States North America California New Mexico

INDUSTRY KEYWORDS: Public Policy/Government State/Local Automotive Utilities EV/Electric Vehicles Alternative Energy Energy

MEDIA:

Logo
Logo
Posted on

Worthington Steel Earns John Deere’s Highest Supplier Rating for 13th Consecutive Year

Worthington Steel Earns John Deere’s Highest Supplier Rating for 13th Consecutive Year

COLUMBUS, Ohio–(BUSINESS WIRE)–
Worthington Steel, Inc. (NYSE: WS) today announced it has once again been recognized as a Partner-level supplier in the John Deere Achieving Excellence Program, marking 13 consecutive years of receiving this honor. Partner-level status is Deere & Company’s highest supplier rating, awarded to companies that demonstrate exceptional quality, service and a commitment to continuous improvement.

“Our 13-year streak as a Partner-level supplier reflects the strength and dedication of our team,” said Geoff Gilmore, president and CEO of Worthington Steel. “We take great pride in delivering innovative steel solutions that help drive John Deere’s success, and we remain focused on raising the bar even higher.”

Members of Worthington Steel’s dedicated John Deere account team will accept the award at John Deere’s annual award ceremony in East Moline, Ill., this morning.

Worthington Steel supplies hot-rolled and cold-rolled cut-to-length steel sheets to John Deere Harvester Works in East Moline, Ill., John Deere Ottumwa Works in Ottumwa, Iowa and John Deere Horicon Works in Horicon, Wis., supporting the production of combine harvesters, hay and forage equipment and utility vehicles.

John Deere’s Achieving Excellence Program evaluates suppliers annually across multiple performance categories, including quality, delivery, process alignment, relationship and value creation. Worthington Steel’s long history of recognition includes John Deere Supplier of the Year awards in 2007 and 2015, a Supplier Innovation award in 2015 and Hall of Fame status in 2016 and 2021 for attaining back-to-back Partner-level ratings for five consecutive years.

About Worthington Steel

Worthington Steel (NYSE:WS) is a metals processor that partners with customers to deliver highly technical and customized solutions. Worthington Steel’s expertise in carbon flat-roll steel processing, electrical steel laminations and tailor welded solutions are driving steel toward a more sustainable future.

As one of the most trusted metals processors in North America, Worthington Steel and its approximately 5,000 employees harness the power of steel to advance our customers’ visions through value-added processing capabilities including galvanizing, pickling, configured blanking, specialty cold reduction, lightweighting and electrical lamination. Headquartered in Columbus, Ohio, Worthington Steel operates 32 facilities in seven states and six countries. Following a people-first Philosophy, commitment to sustainability and proven business system, Worthington Steel’s purpose is to generate positive returns by providing trusted and innovative solutions for customers, creating opportunities for employees and strengthening its communities.

Safe Harbor Statement

Worthington Steel wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995 (the “Act”). Statements by Worthington Steel which are not historical information constitute “forward looking statements” within the meaning of the Act. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected. Factors that could cause actual results to differ materially include risks, uncertainties and impacts described from time to time in Worthington Steel’s filings with the Securities and Exchange Commission.

Melissa Dykstra

Vice President

Corporate Communications and Investor Relations

Phone: 614-840-4144

[email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Automotive Manufacturing Alternative Energy Manufacturing Energy Steel

MEDIA:

Logo
Logo
Posted on

Terreno Realty Corporation Acquires Property in Redmond, WA for $9.3 Million

Terreno Realty Corporation Acquires Property in Redmond, WA for $9.3 Million

BELLEVUE, Wash.–(BUSINESS WIRE)–Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, acquired an industrial property located in Redmond, Washington on April 9, 2025 for a purchase price of approximately $9.3 million.

The property consists of one industrial distribution building containing approximately 33,000 square feet on 1.5 acres. The property is at 9660 153rd Avenue NE on Seattle’s Eastside, provides two dock-high and one grade-level loading positions and parking for 30 cars. The property is 100% leased on a short-term basis. After the existing tenant vacates, the property will be renovated to contain approximately 26,000 square feet. The estimated stabilized cap rate after renovation is 5.5%.

Estimated stabilized cap rates are calculated as annualized cash basis net operating income stabilized to market occupancy (generally 95%) divided by total acquisition cost. Total acquisition cost includes the initial purchase price, the effects of marking assumed debt to market, buyer’s due diligence and closing costs, estimated near-term capital expenditures and leasing costs necessary to achieve stabilization.

Terreno Realty Corporation acquires, owns and operates industrial real estate in six major coastal U.S. markets: New York City/Northern New Jersey, Los Angeles, Miami, San Francisco Bay Area, Seattle and Washington, D.C.

Additional information about Terreno Realty Corporation is available on the company’s web site at www.terreno.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. We caution investors that forward-looking statements are based on management’s beliefs and on assumptions made by, and information currently available to, management. When used, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “result,” “should,” “will,” “seek,” “target,” “see,” “likely,” “position,” “opportunity,” “outlook,” “potential,” “enthusiastic,” “future” and similar expressions which do not relate solely to historical matters are intended to identify forward-looking statements. These statements are subject to risks, uncertainties, and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties, and factors that are beyond our control, including risks related to our ability to meet our estimated forecasts related to stabilized cap rates, and those risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2024 and our other public filings. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated, or projected. We expressly disclaim any responsibility to update our forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on results and trends at the time they are made, to anticipate future results or trends.

Jaime Cannon

415-655-4580

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo
Posted on

BofA Launches ‘Golf with Us’ to Bring Affordable Rounds to More Than 50,000 Youth Nationwide

PR Newswire

Young players can enjoy rounds for $5 or less and instructional opportunities through partnership with Youth on Course


CHARLOTTE, N.C. and MONTEREY, Calif., April 10, 2025/PRNewswire/ — Bank of America today announced the launch of Golf with Us, a new initiative designed to grow the next generation of golfers.

Golf with Us offers youth, ages 6-18, a free one-year membership to Youth on Course, courtesy of Bank of America. Enrollment in the program is open until May 24, 2025, and includes access to thousands of courses in 97 markets for $5 or less per round. The courses are in the Youth on Course network.

“When kids get involved in sports, they learn first-hand about achieving their goals and develop lifelong skills that help them thrive,” said David Tyrie, President, Marketing, Digital & Specialized Consumer Client Solutions, Bank of America. “By working with Youth on Course to help make golf more accessible, we’re helping grow the sport while also making a positive impact in our communities.”

Through Golf with Us, BofA will also bring unique instructional opportunities to youth in select markets throughout the spring, summer and fall by hosting a series of free clinics featuring professional golfers, athletes and celebrities with a passion for golf.

Program membership also includes a registered handicap index in the United States Golf Association’s Golf Handicap Information Network (GHIN) system, continued development as well as learning opportunities. Interested families can enroll in Youth on Course and learn more about the Golf with Us offer at BofA.com/GolfwithUs.

“Golf has the power to shape young lives in incredible ways – not just through the sport itself, but through the friendships, confidence and opportunities it creates,” said Youth on Course CEO Adam Heieck. “Through this partnership with Bank of America, we’re making it possible for more kids across the country to step onto the course and discover what’s possible. This partnership is about more than just golf; it’s about opening doors and changing futures.”

Youth on Course and BofA recently announced a multi-year, strategic partnership to expand golf access across the country for young players who are challenged to find an affordable place to play. As part of the agreement, BofA is helping fund widespread expansion of municipal course locations participating in the program. To date, more than 2,000 courses are Youth on Course partners nationwide.

The bank will promote Golf with Us through a series of commercials beginning during the Masters Tournament. BofA serves as Champion Partner of the Masters Tournament and has partnered with the Augusta National Women’s Amateur since 2019, hosting annual golf clinics for youth in the Augusta, GA area. In 2025, BofA became the presenting partner of the More Than Golf Invitational for female amateur golfers in partnership with the ANNIKA Foundation founded by golfing legend Annika Sorenstam. In addition, BofA has partnered since 2002 with the Latin America Amateur Championship and Asia-Pacific Amateur Championships.

Beyond its growing golf partnership portfolio, BofA also partners with iconic brands in sports that share a vision for excellence and achievement to deepen client relationships, inspire and showcase teammates, create lasting economic impact in communities, and drive growth, globally and locally, through the power of sport. To learn more, visit about.bankofamerica.com/en/making-an-impact/sports 

Bank of America
Bank of America is one of the world’s leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 69 million consumer and small business clients with 3,700 retail financial centers, approximately 15,000 ATMs (automated teller machines) and award-winning digital banking with approximately 58 million verified digital users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 4 million small business households through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and more than 35 countries. Bank of America Corporation stock is listed on the New York Stock Exchange (NYSE: BAC).

Youth on Course


Youth on Course
, a 501(c)3 nonprofit organization headquartered in Monterey, Calif., provides youth 18 and under access to life-changing opportunities through golf. Since its inception in 2006, Youth on Course members have played more than 4 million subsidized rounds of golf for $5 or less at thousands of partner courses throughout the United States, Canada, and Australia. Its members include the top juniors in the sport, competing on the AJGA and Underrated Tours, the inaugural United States Golf Association U.S. National Development Team, and all collegiate levels. The organization forges new pathways for youth to grow in the game via opportunities including the DRIVE Club, Careers on Course, Leadership Council, and its annual College Scholarship awards. The Youth on Course Alumni Network extends membership to those 19 and older, offering opportunities for young adults to connect at complementary events, access exclusive deals, and network with the top employers in the golf industry. Supporters can participate in various initiatives including the Youth on Course 100 Hole Hike, Vintage Cup and Online Auction to help fund golf access for youth. More information about Youth on Course can be found by visiting youthoncourse.org or Facebook, Instagram, LinkedIn, TikTok and X.

Reporters may contact:

Andy Aldridge, Bank of America
Phone: 1.980.387.0514
[email protected]

Daniel Monroe, Youth on Course
Buffalo Groupe
Phone: 843.422.0682
[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bofa-launches-golf-with-us-to-bring-affordable-rounds-to-more-than-50-000-youth-nationwide-302425385.html

SOURCE Bank of America Corporation

Posted on

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program

– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers –

SEATTLE–(BUSINESS WIRE)–
Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia (AML). AML is the most fatal form of leukemia and accounts for approximately 80 percent of acute leukemias in adults and one-third of all cancers affecting the blood/bone marrow, representing a high unmet need. Omeros’ OncotoX program for AML consists of proprietary targeted, engineered molecules (about half the size of an antibody) that deliver a toxic payload within the cancer cells, thereby killing them.

Members of the Omeros Oncology Clinical Steering Committee include:

  • Naval Daver, M.D., Professor and Director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center (Chair of the Omeros Oncology Clinical Steering Committee)
  • Aref Al-Kali, M.D., Chair of the Acute Myeloid Group and Research Chair of the Acute Leukemia and Myeloid Neoplasms Disease Group at Mayo Clinic
  • Jessica K. Altman, M.D., Professor of Medicine in the Division of Hematology and Oncology and Director of the Leukemia Program of Robert H. Lurie Comprehensive Cancer Center at Northwestern University
  • Jayastu Senapati, M.B.B.S., M.D., D.M., Assistant Professor in the Department of Leukemia at MD Anderson Cancer Center
  • Mithun Shah, M.D., Ph.D., Assistant Professor of Medicine and Oncology, and Consultant in the Division of Hematology at Mayo Clinic
  • Anthony S. Stein, M.D., Co-director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies and Stem Cell Transplantation Institute at City of Hope
  • Eytan M. Stein, M.D., Chief of the Leukemia Service and Director of the Program for Drug Development in Leukemia in the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center
  • Roland B. Walter, M.D., Ph.D., M.S., Professor in the Translational Science and Therapeutics Division and José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research at the Fred Hutchinson Cancer Center

The steering committee will, among other activities, assist Omeros with development of the OncotoX-AML program, clinical trial design and interactions with institutional review boards and will participate in OncotoX-AML clinical trials.

“AML is a devastating disease, and these patients have difficulty tolerating the side effects of chemotherapeutic agents and current antibody-drug conjugates, which generally have a narrow therapeutic index,” stated Naval Daver, M.D., Professor and Director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center and Chair of the Omeros Oncology Clinical Steering Committee. “The OncotoX platform is designed to kill only dividing cancer cells while sparing normal cells. In animal models using cell lines derived from AML patients, the OncotoX-AML molecule has shown superior efficacy to current standard of care in AML treatment, and its potential utility extends broadly beyond AML to other types of leukemia. Together with my esteemed physician-scientist colleagues on the steering committee, I look forward to advancing the Omeros therapeutic for AML and bringing this novel treatment to patients as quickly as possible.”

Across extensive in vivo and ex vivo studies, the OncotoX-AML therapeutic has shown to be highly effective even at very low doses, providing a significant survival benefit over currently approved combination therapy (venetoclax and azacytidine). These studies, conducted with human cell lines in well-established animal models and considered predictive of clinical response, have targeted AML tumors with mutational backgrounds commonly found in nearly 90 percent of AML patients (TP53, NPM1, KMT2a, and FLT3) indicating that the OncotoX-AML therapeutic could be “mutation-agnostic,” a currently large unmet need for oncologists and their patients. In studies using primary AML derived from patients, the OncotoX molecule preferentially and efficiently kills AML blasts (abnormal myeloid cells). OncotoX-AML also targets leukemia stem cells (LSC), which are often refractory to chemotherapy and represent another major challenge in the treatment of AML. The OncotoX-AML therapeutic is designed specifically to kill both AML blasts and LSCs that can lead to relapse. Preliminary in vivo tolerability studies demonstrate that the OncotoX therapeutic is well tolerated at doses substantially greater than one order of magnitude above efficacious doses without causing neutropenia or meaningful changes in blood chemistry values.

Omeros is initiating IND-enabling work for its OncotoX-AML therapeutic. Clinical efficacy in AML, considered one of the most aggressive leukemias, is thought to bode well for a therapeutic agent’s broad applicability across leukemias. In addition to OncotoX-AML, Omeros’ portfolio of oncology platforms include signaling and antigen-driven immunomodulators, immune memory-enhancing immunostimulators, and an adoptive T-cell technology that, unlike other cell therapy approaches, does not require cellular engineering.

“We are very pleased to be working with all the members of our oncology steering committee,” said Gregory A. Demopulos, M.D., Omeros’ Chairman and Chief Executive Officer. “Each is an internationally recognized leader in the fields of leukemia and AML and has been integrally involved in the development of new treatments for their patients. Their willingness to invest time and effort in our OncotoX-AML program is a strong endorsement of our molecule’s potential and, with their help, we look forward to assessing this next-generation therapeutic in AML patients.”

In the U.S. alone, AML is diagnosed in over 20,000 patients annually and is responsible each year for more than 11,000 deaths. In 2030, the global AML therapeutic market size is projected to be over $6 billion with the leukemia therapeutic market forecast at $29 billion.

About Omeros’ Oncology Programs

Omeros’ oncology programs are informed by a deep understanding of both the innate (complement-mediated) and adaptive (CD4 & CD8 T-cells) immune systems to derive highly differentiated, first-in-class therapeutic programs to treat a wide range of cancers. While significant progress has been made within oncology through targeted therapies, advanced biologics and immuno-therapies, toxicity and efficacy shortcomings remain significant. Omeros is focused on moving beyond these approaches with a family of wholly novel molecular and cellular platforms designed to be more effective, targeting both cell-surface and intracellular cancer antigens, with less toxicity. Our oncology franchise involves three distinct platforms – OncotoX, immunomodulators, and immunostimulators in combination with adoptive T-cell therapy. IND-enabling work has been initiated to advance to clinic our OncotoX-AML program comprised of engineered molecules designed to target and kill cancer cells with precision. Our immunomodulator platform is based on our identifying and evidencing the importance of certain molecules that selectively target T cells to regulate and potentiate immune responses. Our adoptive T-cell technology, unlike other cell therapy approaches, does not require cellular engineering and is being developed in concert with our immunostimulator platform to advance beyond the challenges of current vaccine approaches, which induce only transient and ineffective immune responses. By combining tumor antigens with a potent adjuvant, these novel, engineered biologics are designed specifically to target and activate antigen-presenting cells, leading to amplification of cancer-specific T and B cells to eliminate existing tumor cells and, importantly, to generate immune memory against future cancer relapse. Collectively, our portfolio of oncology platforms has the potential to deliver substantially more effective and safer treatments broadly across hematological malignancies and solid tumors.

About Omeros Corporation

Omeros is an innovative biopharmaceutical company committed to discovering, developing and commercializing first-in-class small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases and cancers, as well as addictive and compulsive disorders. Omeros’ lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Omeros’ long-acting MASP-2 inhibitor OMS1029 has successfully completed Phase 1 single- and multiple-ascending dose clinical studies. Zaltenibart, Omeros’ inhibitor of MASP-3, the key activator of the alternative pathway of complement, is in Phase 3 clinical development for paroxysmal nocturnal hemoglobinuria and is being evaluated in an ongoing Phase 2 clinical trial for complement 3 glomerulopathy. Funded by the National Institute on Drug Abuse, Omeros’ lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorder. Omeros also is advancing a broad portfolio of novel cellular and molecular immuno-oncology programs. For more information about Omeros and its programs, visit www.omeros.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are subject to the “safe harbor” created by those sections for such statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “goal,” “intend,” “likely,” “look forward to,” “may,” “objective,” “plan,” “potential,” “predict,” “project,” “should,” “slate,” “target,” “will,” “would” and similar expressions and variations thereof. Forward-looking statements, including statements regarding the anticipated safety and therapeutic benefits of Omeros’ drug candidates and plans for future development thereof are based on management’s beliefs and assumptions and on information available to management only as of the date of this press release. Omeros’ actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, our financial condition and results of operations, inability to raise capital when required to fund our operations and development plans, unfavorable, unexpected or inconclusive results of our preclinical and clinical development activities, unexpected outcomes of regulatory processes in relevant jurisdictions, including those associated with other Omeros’ development programs, challenges associated with manufacture or supply of our drug candidates or other materials needed to support preclinical and clinical development, intellectual property claims, competitive developments, litigation, and the risks, uncertainties and other factors described under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2025. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Jennifer Cook Williams

Cook Williams Communications, Inc.

Investor and Media Relations

[email protected]

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Stem Cells Biotechnology Health Pharmaceutical Oncology Health Technology Medical Devices Research Infectious Diseases Science Clinical Trials

MEDIA:

Logo
Logo
Posted on

Global Blue Releases the Monthly Tax Free Shopping Business Update for March 2025

Global Blue Releases the Monthly Tax Free Shopping Business Update for March 2025

  • Fresh data from Global Blue shows a softening in Tax Free Shopping growth across Continental Europe and Asia Pacific.
  • Globally, Issued Sales in Store (like-for-like year-on-year performance) reached +2%1 in March 2025, compared to +10% in February. This softening was influenced by less favourable exchange rates and the shift in the Ramadan calendar2.

SIGNY, Switzerland–(BUSINESS WIRE)–A stable performance in Continental Europe

In Continental Europe, the Issued Sales in Store increased by +7%1 in March compared to +9%1 in February 2025. This performance was driven by a +9%1 increase in the number of shoppers, as in February, while the average spend per shopper softened by -2%1, linked to a less favorable USD/EUR exchange rate.

Among key origin markets, US Tax Free Spend grew by a solid +16%¹ year-on-year, compared with +31% over the last three months3, a deceleration influenced by a less favorable USD/EUR exchange rate. Mainland Chinese shoppers Tax Free Spend recorded a slight rebound at +6%1 versus last year, compared to -4% over the last three months. Meanwhile, GCC shoppers’ Tax Free spend softened to -12%1 versus +21% in February, reflecting the ten-day shift of the beginning of Ramadan compared to 2024. This shift negatively impacted March 2025 figures and is expected to have a positive impact on April 2025 figures.

Across key destination markets, March saw a mixed performance: Spain led with +21%1, France and Italy at +6%1, while Germany was flat1.

A softened performance in Asia Pacific

In Asia Pacific, the Issued Sales in Store growth softened to -7%1 in March 2025, compared to February 2025 (+10%1). This softening was influenced by a less favorable Yen exchange rate and a high basis of comparison. Performance was shaped by a +7%1 increase in the number of shoppers, offset by a -13%1 decline in the average spend per shopper.

Among key origin markets, Tax Free Spend progression softened across most nationalities, impacted by a stronger Yen in Japan. Mainland Chinese Tax Free Spend eased to -1%1 compared to +19% in February. Hong Kong and Taiwan shoppers’ Tax Free Spend recorded a decline at -17% versus -11% in February, while North East Asia shoppers’ Tax Free Spend decreased by -42%1 versus -34% the previous month.

Regarding destination markets, March saw a strong performance in South Korea at +45%1. In contrast, Japan recorded a softening of -7%¹, impacted by less favorable exchange rates, while Singapore eased to -21%¹, impacted by a high basis of comparison.

Worldwide Year-on-Year Growth Rate (2025 vs. 2024)

Issued SIS L/L

Year-on-Year Growth

Destination

market weight in

Issued SIS 2024

 

March

2025

 

February

2025

 

January

2025

 

December

2024

 

CY

Q4 2024

 

CY

Q3 2024

France

 

16%

+6%

+7%

+15%

+19%

+13%

+2%

Italy

 

16%

+6%

+9%

+22%

+24%

+19%

+16%

Spain

 

11%

+21%

+16%

+28%

+22%

+21%

+24%

Germany

 

5%

+0%

+9%

+0%

+14%

+10%

+5%

Other countries

 

16%

+3%

+6%

+21%

+20%

+17%

+10%

Total Continental Europe

 

64%

+7%

+9%

+19%

+20%

+16%

+11%

Japan

 

26%

-7%

+14%

+56%

+32%

+33%

+57%

Singapore

 

6%

-21%

-12%

+8%

+6%

+10%

-3%

South Korea

 

3%

+45%

+50%

+72%

+64%

+50%

+42%

Total Asia Pacific

 

35%

-7%

+10%

+46%

+29%

+29%

+40%

Total Latin America

 

1%

+38%

+50%

+53%

+32%

+33%

+23%

Total worldwide

 

100%

+2%

+10%

+29%

+23%

+21%

+19%

Worldwide Recovery Rate (versus 2019)

Issued SIS L/L

recovery

(in % of 2019)

Destination

market weight in

Issued SIS 2019

 

March

2025

 

February

2025

 

January

2025

 

December

2024

 

CY

Q4 2024

 

CY

Q3 2024

France

 

16%

171%

188%

190%

173%

159%

144%

Italy

 

17%

142%

141%

135%

147%

146%

146%

Spain

 

10%

189%

159%

201%

180%

167%

161%

Germany

 

9%

70%

79%

68%

86%

78%

75%

Other countries

 

19%

132%

151%

149%

140%

132%

126%

Total Continental Europe

 

71%

142%

148%

150%

147%

139%

133%

Japan

 

14%

219%

263%

364%

307%

299%

290%

Singapore

 

11%

89%

75%

99%

77%

83%

81%

South Korea

 

3%

192%

182%

230%

174%

169%

162%

Total Asia Pacific

 

28%

172%

178%

239%

196%

195%

186%

Total Latin America

 

1%

118%

127%

139%

132%

125%

104%

Total worldwide

 

100%

151%

158%

176%

163%

154%

145%

APPENDIX

GLOSSARY

– European Non-EU countries include: Shoppers who can reach destination by land transportation or less than a two hour flight. Ex: Swiss, British, Ukraine etc.

– Gulf Cooperation Council countries include: Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Bahrain, Oman

– North East Asia countries includes: Japan, South Korea

– South East Asia countries includes: Indonesia, Thailand, Cambodia, Philippines, Vietnam, Malaysia, Singapore

ABOUT GLOBAL BLUE

Global Blue is the business partner for the shopping journey, providing technology and services to enhance the experience and drive performance.

With over 40 years of expertise, today we connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across 53 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

With over 2,000 employees, Global Blue generated €28bn Sales in Store and €422M revenue in FY 2023/24. Global Blue is listed on the New York Stock Exchange.

For more information, please visit www.globalblue.com

Global Blue Monthly Intelligence Briefing, March 2025, Source: Global Blue

1Growth rate variation year-on-year (2025 vs. the same period in 2024)

2Ramadan took place from March 10 to April 9 in 2024, and from February 28 to March 30 in 2025.

3Over the last three months: December 2024 – February 2025

MEDIA CONTACTS

Virginie Alem – Chief Marketing Officer and Chief Operating Officer Japan

Mail: [email protected]

KEYWORDS: Kuwait Southeast Asia Viet Nam Singapore Japan Italy Saudi Arabia United Arab Emirates Indonesia Bahrain Hong Kong Qatar Middle East Thailand Philippines Malaysia China Taiwan Oman Germany Asia Pacific Europe Cambodia France Spain South Korea

INDUSTRY KEYWORDS: Payments Online Retail Retail Technology Other Travel Transportation Travel

MEDIA:

Logo
Logo
Posted on

TRILLER COMMUNITIES LAUNCH WITH CELEBRITY-LED FAN HUBS

PR Newswire

Triller Sets the Stage for the Future of Community, Culture and Commerce


LOS ANGELES
, April 10, 2025 /PRNewswire/ — Following its NASDAQ debut and bell-ringing ceremony in Times Square, Triller (ILLR) has unveiled some of the Creators who will be a part of the upcoming launch of Triller Communities, a bold new platform designed to give creators full control of their digital worlds, empower fans to participate meaningfully, and offer brands early access to a culture-shaping ecosystem.

With top creators across music, fashion, fitness, sports, and lifestyle already signed on—including JustMaiko, Bella Blaq, JR Warren, and Clifford Taylor IV—Triller is becoming a launchpad for immersive, creator-led fan hubs. These are more than feeds—they’re self-contained, interactive communities where fans can engage directly and access exclusive content.

What sets Triller apart is its growing network of fan-powered Community Managers, thousands of users volunteering to help run and grow their favorite creators’ communities. This model transforms followers into collaborators, fueling a new kind of fan economy with shared ownership and reward.

“We’re building the future of social,” said Triller app CEO Sean Kim. “Triller Communities give creators ownership, fans a seat at the table, and brands a front-row seat to culture.” SVP of Technology Operations Manoj Malhotra added, “Each community is a fully customizable, scalable network. This is real infrastructure.”

With creators spanning diverse verticals and organizations like Empire Records joining in, Triller’s ecosystem is growing fast— and so is brand interest. “We see Triller Communities as the next evolution of brand storytelling—where we don’t just sponsor culture, we help shape it,” said Daniella Gallego, VP of Marketing at Triller. “Several brands are jumping at the opportunity to be early adopters, capitalizing on the migration of leading creators and their fans.”

As creators migrate their audiences to Triller, brands have a rare opportunity to integrate, not interrupt. By partnering with creators and Community Managers, they can launch drops, co-create events, and build relevance with Gen Z and Millennial audiences in authentic, organic ways.

For creators, it’s ownership. For fans, it’s a seat at the table. For brands, it’s cultural credibility. And for Triller, it’s just the beginning.

As Kim puts it: “We’re not just building tools. We’re building digital nations—and we’re inviting the world in.”


About Triller Group Inc.
 (Nasdaq: ILLR) Triller Group Inc. is a technology powerhouse with a portfolio of high-growth businesses poised to break through in the Creator Economy. Triller App is the most creator-focused social platform offering discovery, monetization, and ownership. Supported by Triller Platform, it serves as a cutting-edge social media platform designed for creators, offering innovative tools for content creation, marketing, and brand partnerships. It enables creators to connect with fans, monetize their work, and build meaningful relationships with brands.

Bare Knuckle Fighting Championship (BKFC) stages live and streaming combat sports events that are rapidly gaining popularity with fans globally. With a focus on exciting matchups and high-energy performances, BKFC has established itself as the fastest-growing combat league in the industry. TrillerTV is Triller Group’s premier live streaming platform, showcasing a diverse array of in-house and third-party sports and entertainment content. With its robust infrastructure, TrillerTV is committed to delivering high-quality live events that captivate audiences and drive subscriber growth.

Additionally, AGBA serves as a one-stop financial supermarket, providing independent distribution of a wide range of financial products and services. By connecting consumers with essential financial solutions, AGBA enhances Triller Group’s ecosystem, making it easier for users to access the tools they need for financial success.

Together, these diverse businesses form a unique and integrated ecosystem that positions Triller Group at the forefront of innovation in social media, live entertainment, combat sports, and financial services. For more information about our businesses, visit www.trillercorp.com and www.agba.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; product and service demand and acceptance; changes in technology; economic conditions; the outcome of any legal proceedings that may be instituted against us following the consummation of the business combination; expectations regarding our strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Hong Kong and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/triller-communities-launch-with-celebrity-led-fan-hubs-302425653.html

SOURCE Triller Corp

Posted on

Federated Hermes Premier Municipal Income Fund declares dividend

PR Newswire


PITTSBURGH
, April 10, 2025 /PRNewswire/ — Federated Hermes Premier Municipal Income Fund (NYSE: FMN) has declared a dividend. The fund seeks to provide investors with current dividend income that is exempt from regular federal income tax. In addition, this fund features income exempt from the federal alternative minimum tax (AMT).



Tax-Free Dividend Per Share


Record Date:

April 23, 2025


Ex-Dividend Date:

April 23, 2025


Payable Date: 

May 1, 2025


Amount



Change From Previous Month

$0.0400

$0.0000

 

Investors can view additional portfolio information in the Products section of FederatedHermes.com/us.

Federated Hermes, Inc. (NYSE: FHI) is a global leader in active investment management, with $829.6 billion in assets under management, as of Dec. 31, 2024. We deliver investment solutions that help investors target a broad range of outcomes and provide equity, fixed-income, alternative/private markets, multi-asset and liquidity management strategies to more than 10,000 institutions and intermediaries worldwide. Our clients include corporations, government entities, insurance companies, foundations and endowments, banks and broker/dealers. Headquartered in Pittsburgh, Federated Hermes has more than 2,000 employees in London, New York, Boston and offices worldwide. For more information, visit FederatedHermes.com/us.

###

Cision View original content:https://www.prnewswire.com/news-releases/federated-hermes-premier-municipal-income-fund-declares-dividend-302425650.html

SOURCE Federated Hermes, Inc.

Posted on

Academy Sports + Outdoors Teams Up with Babe Ruth League to Support Youth Baseball and Softball Across the Country

PR Newswire

Academy to serve as the Official Sporting Goods Retailer of Babe Ruth League beginning in 2025


KATY, Texas
, April 10, 2025 /PRNewswire/ — Academy Sports + Outdoors (“Academy”) (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce a multi-year partnership with Babe Ruth League, serving as the league’s Official Sporting Goods Retailer. By combining resources and expertise, the two organizations aim to help youth athletes from across the country develop their skills, build confidence, and cultivate a lifelong love for baseball and softball. Babe Ruth League athletes, coaches, and their families will receive exclusive benefits and high-quality sporting goods, equipment, and apparel from Academy to enhance their experience both on and off the field.

“Academy is thrilled to partner with Babe Ruth League to make baseball and softball more available to youth athletes while also helping them to have fun and enjoy the outdoors,” said Chris Woods, Director of Regional Marketing at Academy Sports + Outdoors. “Together, we’re looking forward to enriching the experience of youth athletes and fostering a lifelong passion of baseball and softball.”

This new collaboration underscores Academy Sports + Outdoors’ commitment to supporting local communities and encouraging access to and participation in youth sports. Through this partnership, Babe Ruth Leagues across the country will benefit from equipment support, special promotions, and other valuable resources to ensure young athletes have the tools they need to succeed.

“We are incredibly excited to welcome Academy Sports + Outdoors as an official partner of Babe Ruth League,” said Rob Conner, Vice President of Babe Ruth League, Inc. “Their dedication to providing top-tier sporting goods and their commitment to supporting youth sports aligns perfectly with our goals. This partnership will allow us to provide even more opportunities and resources for our leagues, ensuring that every player has access to the equipment they need to enjoy and excel in the game.”

The Babe Ruth League, Inc. is committed to providing participants with the best educational sports experience. The program teaches skills, mental and physical development, a respect for the rules of the game, and basic ideals of sportsmanship and fair play. Using regulation competitive baseball and softball rules, Babe Ruth League caters to more than one million players nationwide. For more information about Babe Ruth League, visit baberuthleage.com.

To learn more about Academy Sports + Outdoors, visit academy.com.

About Academy Sports + Outdoors
Academy is a leading full-line sporting goods and outdoor recreation retailer in the United States. Originally founded in 1938 as a family business in Texas, Academy has grown to more than 300 stores across 21 states and counting. Academy’s mission is to provide “Fun for All” and Academy fulfills this mission with a localized merchandising strategy and value proposition that strongly connects with a broad range of consumers. Academy’s product assortment focuses on key categories of outdoor, apparel, sports & recreation and footwear through both leading national brands and a portfolio of private label brands. For more information, visit www.academy.com.

About Babe Ruth League
Founded in 1951, Babe Ruth League, Inc. is a world-class youth baseball and softball organization committed to teaching young athletes sportsmanship, teamwork, and leadership through the game. baberuthleague.org

Media Contact: Shane Carlisle, Public Relations Manager, [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/academy-sports–outdoors-teams-up-with-babe-ruth-league-to-support-youth-baseball-and-softball-across-the-country-302425020.html

SOURCE Academy Sports + Outdoors